Regulation of immune tolerance by anti-inflammatory neuropeptides

[1]  Mario Delgado,et al.  Therapeutic effect of urocortin on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of regulatory T cells. , 2007, Arthritis and rheumatism.

[2]  A. Chorny,et al.  Therapeutic effect of cortistatin on experimental arthritis by downregulating inflammatory and Th1 responses , 2006, Annals of the rheumatic diseases.

[3]  A. Chorny,et al.  Adrenomedullin protects from experimental arthritis by down-regulating inflammation and Th1 response and inducing regulatory T cells. , 2007, The American journal of pathology.

[4]  D. Pozo,et al.  Protective Role for Plasmid DNA‐Mediated VIP Gene Transfer in Non‐Obese Diabetic Mice , 2006, Annals of the New York Academy of Sciences.

[5]  G. Robledo,et al.  Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response. , 2006, The American journal of pathology.

[6]  A. Chorny,et al.  Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn’s disease , 2006, Gut.

[7]  A. Chorny,et al.  Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. , 2006, Blood.

[8]  A. Chorny,et al.  Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response. , 2006, Blood.

[9]  Javier Martín,et al.  Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses. , 2006, The American journal of pathology.

[10]  G. Robledo,et al.  Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia , 2006, The Journal of experimental medicine.

[11]  A. Chorny,et al.  Cortistatin, an antiinflammatory peptide with therapeutic action in inflammatory bowel disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Chorny,et al.  Vasoactive intestinal peptide induces CD4+,CD25+ T regulatory cells with therapeutic effect in collagen-induced arthritis. , 2006, Arthritis and rheumatism.

[13]  A. Chorny,et al.  Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis , 2006, European journal of immunology.

[14]  A. Chorny,et al.  Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD 4 and CD 8 regulatory T cells , 2006 .

[15]  A. Chorny,et al.  Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo , 2005, Journal of leukocyte biology.

[16]  E. González-Rey,et al.  The Neuropeptide Vasoactive Intestinal Peptide Generates Tolerogenic Dendritic Cells1 , 2005, The Journal of Immunology.

[17]  David Pozo,et al.  Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Joachim Spiess,et al.  Urocortin 1 and Urocortin 2 induce macrophage apoptosis via CRFR2 , 2005, FEBS letters.

[19]  C. Martínez,et al.  Time‐course expression of Toll‐like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP , 2005, Journal of leukocyte biology.

[20]  A. Margioris,et al.  The corticotropin-releasing factor (CRF) family of neuropeptides in inflammation: potential therapeutic applications. , 2005, Current medicinal chemistry.

[21]  S. L. la Fleur,et al.  Role of peripheral corticotropin-releasing factor and urocortin II in intestinal inflammation and motility in terminal ileum. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Andrew W. Taylor,et al.  The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (α-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages , 2005, Journal of Neuroimmunology.

[23]  Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: Advances in the development of specific phosphodiesterase inhibitors , 2005, Medicinal research reviews.

[24]  B. Cheung,et al.  Adrenomedullin is both proinflammatory and antiinflammatory: its effects on gene expression and secretion of cytokines and macrophage migration inhibitory factor in NR8383 macrophage cell line. , 2005, Endocrinology.

[25]  J. Blalock.  The immune system as the sixth sense , 2005, Journal of internal medicine.

[26]  H. Waldmann,et al.  Regulatory T cells in transplantation tolerance. , 2005, Current topics in microbiology and immunology.

[27]  D. Wraith,et al.  Regulatory CD4+ T cells and the control of autoimmune disease. , 2004, Current opinion in immunology.

[28]  H. Sasano,et al.  Localization and physiological roles of urocortin , 2004, Peptides.

[29]  E. González-Rey,et al.  VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  T. Hattori,et al.  Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide. , 2004, Archives of ophthalmology.

[31]  D. Taub,et al.  Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. , 2004, The Journal of clinical investigation.

[32]  E. Goetzl,et al.  c-Maf and JunB Mediation of Th2 Differentiation Induced by the Type 2 G Protein-Coupled Receptor (VPAC2) for Vasoactive Intestinal Peptide1 , 2004, The Journal of Immunology.

[33]  M. Delgado,et al.  VIP/PACAP oppositely affects immature and mature dendritic cell expression of CD80/CD86 and the stimulatory activity for CD4+ T cells , 2004, Journal of leukocyte biology.

[34]  D. Pozo,et al.  The Significance of Vasoactive Intestinal Peptide in Immunomodulation , 2004, Pharmacological Reviews.

[35]  S. Zheng,et al.  Natural and Induced CD4+CD25+ Cells Educate CD4+CD25− Cells to Develop Suppressive Activity: The Role of IL-2, TGF-β, and IL-101 , 2004, The Journal of Immunology.

[36]  A. Thomson,et al.  Dendritic cells: emerging pharmacological targets of immunosuppressive drugs , 2004, Nature Reviews Immunology.

[37]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[38]  S. Manna,et al.  α‐Melanocyte‐stimulating hormone inhibits lipopolysaccharide‐induced biological responses by downregulating CD14 from macrophages , 2003, FEBS letters.

[39]  S. Goh,et al.  α-Melanocyte-stimulating Hormone Inhibits Lipopolysaccharide-induced Tumor Necrosis Factor-α Production in Leukocytes by Modulating Protein Kinase A, p38 Kinase, and Nuclear Factor κB Signaling Pathways* , 2003, Journal of Biological Chemistry.

[40]  E. Martı́n-Mola,et al.  Effect of calcitonin gene-related peptide, neuropeptide Y, substance P, and vasoactive intestinal peptide on interleukin-1β, interleukin-6 and tumor necrosis factor-alpha production by peripheral whole blood cells from rheumatoid arthritis and osteoarthritis patients , 2003, Regulatory Peptides.

[41]  T. Luger,et al.  New Insights into the Functions of α‐MSH and Related Peptides in the Immune System , 2003 .

[42]  M. Delgado,et al.  Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease. , 2003, Gastroenterology.

[43]  Y. Nishiyama,et al.  VIPase autoantibodies in Fas‐defective mice and patients with autoimmune disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  Katsuaki Sato,et al.  Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. , 2003, Immunity.

[45]  R. Hauger,et al.  International Union of Pharmacology. XXXVI. Current Status of the Nomenclature for Receptors for Corticotropin-Releasing Factor and Their Ligands , 2003, Pharmacological Reviews.

[46]  E. Goetzl,et al.  Roles of Vasoactive Intestinal Peptide (VIP) in the Expression of Different Immune Phenotypes by Wild-Type Mice and T Cell-Targeted Type II VIP Receptor Transgenic Mice1 , 2003, The Journal of Immunology.

[47]  M. Tzardi,et al.  Urocortin in human gastric mucosa: relationship to inflammatory activity. , 2003, The Journal of clinical endocrinology and metabolism.

[48]  A. Langerak,et al.  Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system. , 2003, The Journal of clinical endocrinology and metabolism.

[49]  J. M. Lipton,et al.  &agr;-Melanocyte-stimulating hormone protects the allograft in experimental heart transplantation1 , 2002 .

[50]  Sofia Agelaki,et al.  Corticotropin-Releasing Hormone Augments Proinflammatory Cytokine Production from Macrophages In Vitro and in Lipopolysaccharide-Induced Endotoxin Shock in Mice , 2002, Infection and Immunity.

[51]  K. Namba,et al.  Induction of regulatory T cells by the immunomodulating cytokines α‐melanocyte‐stimulating hormone and transforming growth factor‐β2 , 2002, Journal of Leukocyte Biology.

[52]  M. Delgado,et al.  Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide promote in vivo generation of memory Th2 cells , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  Ethan M. Shevach,et al.  CD4+CD25+ suppressor T cells: more questions than answers , 2002, Nature Reviews Immunology.

[54]  Patrick M. Sexton,et al.  International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors , 2002, Pharmacological Reviews.

[55]  T. Elsasser,et al.  Adrenomedullin has multiple roles in disease stress: Development and remission of the inflammatory response , 2002, Microscopy research and technique.

[56]  H. Pons,et al.  Substance P and calcitonin gene-related peptide increase IL-1β, IL-6 and TNFα secretion from human peripheral blood mononuclear cells , 2002, Neurochemistry International.

[57]  J. M. Lipton,et al.  alpha-Melanocyte-stimulating hormone protects the allograft in experimental heart transplantation. , 2002, Transplantation.

[58]  R. Petrovska,et al.  MC1 receptors are constitutively expressed on leucocyte subpopulations with antigen presenting and cytotoxic functions , 2001, Clinical and experimental immunology.

[59]  E. Goetzl,et al.  Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC2 receptor for vasoactive intestinal peptide , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[60]  E. Goetzl,et al.  Allergic diathesis in transgenic mice with constitutive T cell expression of inducible vasoactive intestinal peptide receptor , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[61]  K. Karalis,et al.  Corticotropin-releasing hormone regulates IL-6 expression during inflammation. , 2001, The Journal of clinical investigation.

[62]  K. Namba,et al.  In vitro induction of CD25+ CD4+ regulatory T cells by the neuropeptide alpha‐melanocyte stimulating hormone (α‐MSH) , 2001, Immunology and cell biology.

[63]  M. Delgado,et al.  Inhibition of Endotoxin-Induced Macrophage Chemokine Production by Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-Activating Polypeptide In Vitro and In Vivo1 , 2001, The Journal of Immunology.

[64]  Mario Delgado,et al.  Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease , 2001, Nature Medicine.

[65]  M. Delgado,et al.  Cutting Edge: Is Vasoactive Intestinal Peptide a Type 2 Cytokine? , 2001, The Journal of Immunology.

[66]  Z. Abdel‐Malek.  Melanocortin receptors: their functions and regulation by physiological agonists and antagonists , 2001, Cellular and Molecular Life Sciences CMLS.

[67]  M. Delgado,et al.  Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Nuclear Factor-κB-dependent Gene Activation at Multiple Levels in the Human Monocytic Cell Line THP-1* , 2001, The Journal of Biological Chemistry.

[68]  M. Papotti,et al.  Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland , 2001, Journal of endocrinological investigation.

[69]  S. Krantic.  Peptides as regulators of the immune system: emphasis on somatostatin , 2000, Peptides.

[70]  L. Lecea,et al.  Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions , 2000, Brain Research Reviews.

[71]  J. Bienvenu,et al.  Procalcitonin and calcitonin gene-related peptide decrease LPS-induced tnf production by human circulating blood cells. , 2000, Cytokine.

[72]  K. Kangawa,et al.  Decreased gene expression of adrenomedullin receptor in mouse lungs during sepsis. , 2000, Biochemical and biophysical research communications.

[73]  D. Smith,et al.  Adrenomedullin, a multifunctional regulatory peptide. , 2000, Endocrine reviews.

[74]  M. Tunçel,et al.  Vasoactive intestinal peptide inhibits degranulation and changes granular content of mast cells: a potential therapeutic strategy in controlling septic shock , 2000, Peptides.

[75]  J. Blalock.  Proopiomelanocortin and the Immune‐Neuroendocrine Connection , 1999, Annals of the New York Academy of Sciences.

[76]  M. Hadley,et al.  The Proopiomelanocortin System , 1999, Annals of the New York Academy of Sciences.

[77]  M. Delgado,et al.  Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide stimulate the induction of Th2 responses by up-regulating B7.2 expression. , 1999, Journal of immunology.

[78]  S. Grabbe,et al.  Human Peripheral Blood‐Derived Dendritic Cells Express Functional Melanocortin Receptor MC‐1R , 1999, Annals of the New York Academy of Sciences.

[79]  A. Taylor,et al.  Specific aqueous humor factors induce activation of regulatory T cells. , 1999, Investigative ophthalmology & visual science.

[80]  M. Delgado,et al.  Shedding of membrane-bound CD14 from lipopolysaccharide-stimulated macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide , 1999, Journal of Neuroimmunology.

[81]  M. Perretti,et al.  POMC gene-derived peptides activate melanocortin type 3 receptor on murine macrophages, suppress cytokine release, and inhibit neutrophil migration in acute experimental inflammation. , 1999, Journal of immunology.

[82]  E. Muñoz-Elías,et al.  VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T cells , 1999, Journal of Neuroimmunology.

[83]  J. M. Lipton,et al.  α-MSH and its receptors in regulation of tumor necrosis factor-α production by human monocyte/macrophages. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[84]  E. Muñoz-Elías,et al.  Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation. , 1999, Journal of immunology.

[85]  D. Pozo,et al.  Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies. , 1999, Journal of immunology.

[86]  E. Muñoz-Elías,et al.  Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. , 1999, Journal of immunology.

[87]  D. Pozo,et al.  Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activation Polypeptide (PACAP) Protect Mice from Lethal Endotoxemia Through the Inhibition of TNF-α and IL-6 , 1999, The Journal of Immunology.

[88]  W. Vale,et al.  Printed in U.S.A. Copyright © 1999 by The Endocrine Society Urocortin Messenger Ribonucleic Acid: Tissue Distribution in the Rat and Regulation in Thymus by , 1999 .

[89]  P. Ghezzi,et al.  Corticosteroid-independent inhibition of tumor necrosis factor production by the neuropeptide urocortin. , 1998, American journal of physiology. Endocrinology and metabolism.

[90]  N. Minamino,et al.  Production of Adrenomedullin in Macrophage Cell Line and Peritoneal Macrophage* , 1998, The Journal of Biological Chemistry.

[91]  S. Rawlings,et al.  International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. , 1998, Pharmacological reviews.

[92]  J. M. Lipton,et al.  Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia , 1998, Journal of leukocyte biology.

[93]  D. Pozo,et al.  Vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide modulate endotoxin‐induced IL‐6 production by murine peritoneal macrophages , 1998, Journal of leukocyte biology.

[94]  J. Buggy.  Binding of alpha-melanocyte-stimulating hormone to its G-protein-coupled receptor on B-lymphocytes activates the Jak/STAT pathway. , 1998, The Biochemical journal.

[95]  J. M. Lipton,et al.  α-MSH Modulates Experimental Inflammatory Bowel Disease , 1997, Peptides.

[96]  S. Felten,et al.  Vasoactive Intestinal Polypeptide (VIP) Innervation of Rat Spleen, Thymus, and Lymph Nodes , 1997, Peptides.

[97]  C. Janeway,et al.  Innate Immunity: The Virtues of a Nonclonal System of Recognition , 1997, Cell.

[98]  M. Heck,et al.  Condensins, Cohesins, and Chromosome Architecture: How to Make and Break a Mitotic Chromosome , 1997, Cell.

[99]  N. Ling,et al.  Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system. , 1997, Journal of immunology.

[100]  J. M. Lipton,et al.  Anti-inflammatory actions of the neuroimmunomodulator α-MSH , 1997 .

[101]  S. Correa,et al.  Modulation of the inflammatory response by corticotropin-releasing factor. , 1997, European journal of pharmacology.

[102]  J. M. Lipton,et al.  The neuropeptide α-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro , 1996, Peptides.

[103]  Á. Hernanz,et al.  Differential effects of gastrin-releasing peptide, neuropeptide Y, somatostatin and vasoactive intestinal peptide on interleukin-1β, interleukin-6 and tumor necrosis factor-α production by whole blood cells from healthy young and old subjects , 1996, Journal of Neuroimmunology.

[104]  V. Kuchroo,et al.  B7-2 (CD86) is essential for the development of IL-4-producing T cells. , 1996, International immunology.

[105]  Á. Hernanz,et al.  Relationship between circulating levels of calcitonin gene-related peptide, nitric oxide metabolites and hemodynamic changes in human septic shock , 1996, Regulatory Peptides.

[106]  J. M. Lipton,et al.  Alpha-melanocyte-stimulating hormone reduces endotoxin-induced liver inflammation. , 1996, The Journal of clinical investigation.

[107]  Y. Aragane,et al.  Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. , 1996, Journal of immunology.

[108]  J. M. Lipton,et al.  Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[109]  J. M. Lipton,et al.  The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats. , 1994, Neuroimmunomodulation.

[110]  T. Jenssen,et al.  Vasoactive intestinal polypeptide and somatostatin in leucocytes. , 1984, Scandinavian journal of clinical and laboratory investigation.

[111]  R. Rosenberg,et al.  Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue. , 1976, Science.

[112]  V. Mutt,et al.  Polypeptide with Broad Biological Activity: Isolation from Small Intestine , 1970, Science.